Surgical treatment of pancreatic endocrine neoplasms

American Journal of Surgery

Volumn 193, Issue 4, 2007, Pages 460-465

  Gomez Rivera, Fernando ^a   Stewart, Ashley E ^a   Arnoletti, J Pablo ^a   Vickers, Selwyn ^a   Bland, Kirby I ^a   Heslin, Martin J ^a  

^a Kentucky   (United States)

Author keywords

Gastrinoma; Insulinoma; Pancreatic endocrine neoplasm

Indexed keywords

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE COURSE; ENDOCRINE TUMOR; FEMALE; FOLLOW UP; FUNCTIONAL ANATOMY; HUMAN; LIVER METASTASIS; MALE; PANCREAS TUMOR; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ENDOCRINE GLAND NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33947140991     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.10.016     Document Type: Article

References (19)

1. Muscarella P., and Ellison E.C. Pancreatic islet cell tumors excluding gastrinoma. In: Cameron J.L. (Ed). Current Surgical Therapy (2004), Elsevier Mosby, Philadelphia, PA 520-525
2. Azimuddin K., and Chamberlain R.S. The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am 81 (2001) 511-525
3. Liang H., Wang P., Wang X.N., et al. Management of nonfunctioning islet cell tumors. World J Gastroenterol 10 (2004) 1806-1809
4. Madeira I., Terris B., Voss M., et al. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 43 (1998) 422-427
5. Matthews B.D., Smith T.I., Kercher K.W., et al. Surgical experience with functioning pancreatic neuroendocrine tumors. Am Surg 68 (2002) 660-665
6. Pape U.F., Bohmig M., Berndt U., et al. Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center. Ann N Y Acad Sci 1014 (2004) 222-233
7. Phan G.Q., Yeo C.J., Hruban R.H., et al. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 2 (1998) 472-482
8. Chu Q.D., Hill H.C., Douglass Jr. H.O., et al. Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas. Ann Surg Oncol 9 (2002) 855-862
9. Eckhauser F.E., Cheung P.S., Vinik A.I., et al. Nonfunctioning malignant neuroendocrine tumors of the pancreas. Surgery 100 (1986) 978-988
10. Legaspi A., and Brennan M.F. Management of islet cell carcinoma. Surgery 104 (1988) 1018-1023
11. McEntee G.P., Nagorney D.M., Kvols L.K., et al. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 108 (1990) 1091-1096
12. Norton J.A., Sugarbaker P.H., Doppman J.L., et al. Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg 203 (1986) 352-359
13. Thompson G.B., van Heerden J.A., Grant C.S., et al. Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery 104 (1988) 1011-1017
14. Norton J.A., Kivlen M., Li M., et al. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg 138 (2003) 859-866
15. Chamberlain R.S., Canes D., Brown K.T., et al. Hepatic neuroendocrine metastases: does intervention alter outcomes?. J Am Coll Surg 190 (2000) 432-445
16. Touzios J.G., Kiely J.M., Pitt S.C., et al. Neuroendocrine hepatic metastases: does aggressive management improve survival?. Ann Surg 241 (2005) 776-783
17. Lo C.Y., van Heerden J.A., Thompson G.B., et al. Islet cell carcinoma of the pancreas. World J Surg 20 (1996) 878-883
18. Grama D., Eriksson B., Martensson H., et al. Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes. World J Surg 16 (1992) 632-639
19. White T.J., Edney J.A., Thompson J.S., et al. Is there a prognostic difference between functional and nonfunctional islet cell tumors?. Am J Surg 168 (1994) 627-629